Works matching IS 02704137 AND DT 2006 AND VI 66 AND IP 16

Results: 10

Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor on tumor‐associated endothelial cellsJ. Erik Busby and Sun‐Jin Kim contributed equally to this work.

Published in:

Prostate, 2006, v. 66, n. 16, p. 1788, doi. 10.1002/pros.20519

By:

J. Erik Busby;
Sun‐Jin Kim;
Sertac Yazici;
Toru Nakamura;
Jang‐Seong Kim;
Junqin He;
Marva Maya;
Xuemei Wang;
Kim‐Anh Do;
Dominic Fan;
Isaiah J. Fidler

Publication type:

Article

Absence of Bcl‐2 expression favors response to the short‐term administration of diethylstilbestrol diphosphate in prostate Cancer.

Published in:

Prostate, 2006, v. 66, n. 16, p. 1779, doi. 10.1002/pros.20515

By:

Akira Nagaoka;
Yoko Kubota;
Seiichi Kurosu;
Teruhiro Nakada;
Vladimir Bilim;
Yosihiko Tomita;
Teiichi Motoyama

Publication type:

Article

Identification of ABR‐215050 as lead second generation quinoline‐3‐carboxamide anti‐angiogenic agent for the treatment of prostate cancer.

Published in:

Prostate, 2006, v. 66, n. 16, p. 1768, doi. 10.1002/pros.20509

By:

John T. Isaacs;
Roberto Pili;
David Z. Qian;
Susan L. Dalrymple;
Jason B. Garrison;
Natasha Kyprianou;
Anders Björk;
Anders Olsson;
Tomas Leanderson

Publication type:

Article

Control of prostate cancer spheroid growth using 213Bi‐labeled multiple targeted α radioimmunoconjugates.

Published in:

Prostate, 2006, v. 66, n. 16, p. 1753, doi. 10.1002/pros.20502

By:

Jian Wang;
Syed M. Abbas Rizvi;
Michele C. Madigan;
Paul J. Cozzi;
Carl A. Power;
Chang F. Qu;
Alfred Morgenstern;
Christos Apostolidis;
Pamela J. Russell;
Barry J. Allen;
Yong Li

Publication type:

Article

Regulation of growth of prostate cancer cells selected in the presence of interleukin‐6 by the anti‐interleukin‐6 antibody CNTO 328Hannes Steiner and Ilaria T. Cavarretta are joint first authors of the manuscript.

Published in:

Prostate, 2006, v. 66, n. 16, p. 1744, doi. 10.1002/pros.20492

By:

Hannes Steiner;
Ilaria T. Cavarretta;
Patrizia L. Moser;
Andreas P. Berger;
Jasmin Bektic;
Hermann Dietrich;
Mohamed H. Zaki;
Marian Nakada;
Alfred Hobisch;
Jeffrey A. Nemeth;
Zoran Culig

Publication type:

Article

Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathwaySara Lindström and S Lilly Zheng contributed equally to this work.

Published in:

Prostate, 2006, v. 66, n. 16, p. 1729, doi. 10.1002/pros.20489

By:

Sara Lindström;
S. Lilly Zheng;
Fredrik Wiklund;
Björn‐Anders Jonsson;
Hans‐Olov Adami;
Katarina Augustsson Bälter;
Anthony J. Brookes;
Jielin Sun;
Bao‐Li Chang;
Wennuan Liu;
Ge Li;
William B. Isaacs;
Jan Adolfsson;
Henrik Grönberg;
Jianfeng Xu

Publication type:

Article

Critical and opposing roles of the chemokine receptors CXCR2 and CXCR3 in prostate tumor growth.

Published in:

Prostate, 2006, v. 66, n. 16, p. 1721, doi. 10.1002/pros.20476

By:

Hui Shen;
Rebecca Schuster;
Bao Lu;
Susan E. Waltz;
Alex B. Lentsch

Publication type:

Article

Presence of prostate cancer metastasis correlates with lower lymph node reactivityResearch was performed at CR‐CHUM, Institut du cancer de Montréal, Hôpital Notre‐Dame (CHUM), 1560 rue Sherbrooke Est (Y‐4609), Montréal, Québec, Canada, H2L 4M1.

Published in:

Prostate, 2006, v. 66, n. 16, p. 1710, doi. 10.1002/pros.20466

By:

Gannon Philippe Olivier;
Alam Fahmy Mona;
Bégin Louis Réal;
Djoukhadjian Audrey;
Filali‐Mouhim Abdelali;
Lapointe Réjean;
Mes‐Masson Anne‐Marie;
Saad Fred

Publication type:

Article

Relaxin becomes upregulated during prostate cancer progression to androgen independence and is negatively regulated by androgens.

Published in:

Prostate, 2006, v. 66, n. 16, p. 1698, doi. 10.1002/pros.20423

By:

Vanessa C. Thompson;
Tanis G.W. Morris;
Dawn R. Cochrane;
John Cavanagh;
Latif A. Wafa;
Tatyana Hamilton;
Shunyou Wang;
Ladan Fazli;
Martin E. Gleave;
Colleen C. Nelson

Publication type:

Article

Castration rapidly decreases local insulin‐like growth factor‐1 levels and inhibits its effects in the ventral prostate in mice.

Published in:

Prostate, 2006, v. 66, n. 16, p. 1687, doi. 10.1002/pros.20368

By:

Nina Ohlson;
Anders Bergh;
Malin Lindhagen Persson;
Pernilla Wikström

Publication type:

Article